Total Funding
39
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
39740
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
- Robert Hershberg: Co-Founder and CEOPast Role: Celgene, Executive Vice President and Head of Business Development and Global Alliances
- Sean McLoughlin: Chief Operating Officer
About the Company
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.
HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.
